baber/WOPTO huggingface dataset:
Patent SG-143256-A1 (SG)
Title: Method, wireless handheld electronic device and system of remotely controlling e-mail settings from the device
Inventor: BOCKING ANDREW D
IPC: G06Q10/00
Filed: 2005-10-18
Abstract: METHOD, WIRELESS HANDHELD ELECTRONIC DEVICE AND SYSTEM OF REMOTELY CONTROLLING E-MAIL SETTINGS FROM THE DEVICE A system includes a wireless handheld electronic device having a plurality of e-mail settings associated therewith. A plurality of servers include an e- mail server and a wireless enterprise server having a database maintaining at least one of the e-mail settings. The wireless enterprise server is adapted to wirelessly communicate with the wireless handheld electronic device. The wireless handheld electronic device is adapted to remotely control at least one of the e- mail settings at the wireless enterprise server through wireless communication between the wireless enterprise server and the wireless handheld electronic device.
Patent SG-143281-A1 (SG)
Title: High frequency receiver preamplifier with cmos rail-to-rail capability
Inventor: LIM HONG SAIR
Filed: 2005-04-14
Abstract: HIGH FREQUENCY RECEIVER PREAMPLIFIER WITH CMOS RAIL-TO-RAIL CAPABILITY A folded cascade receiver amplifier with constant gain has inputs coupled to PMOS and NMOS differential transistors pairs with scaled geometries. The transconductance of both PMOS and NMOS transistors is the same whether the common mode input voltage is low or high. In a first version the transconductance of both PMOS and NMOS differential transistor pairs is reduced when the common mode input voltage is at mid-rail. Resistive means between current sources and the sources of the PMOS and NMOS transistor pairs force the current source transistors into the triode region of operation. A second version insures a constant voltage gain through control means which maintain a constant ratio of the transconductance of the output stage transistors versus the PMOS and NMOS differential transistor pairs when active.
Patent SG-157973-A1 (SG)
Title: Method for growing monocrystalline diamonds
Inventor: MISRA DEVI SHANKER
Filed: 2008-06-18
Abstract: A method of forming mono-crystalline diamond by chemical vapour deposition, the method comprising the steps of: (a) providing at least one diamond seed; (b) exposing the seed to conditions for growing diamond by chemical vapour deposition, including supplying reaction gases that include a carbon- containing gas and hydrogen for growing diamond and include a nitrogen- containing gas; and (c) controlling the quantity of nitrogen-containing gas relative to other gases in the reaction gases such that diamond is caused to grow by step- growth with defect free steps without inclusions. The nitrogen is present in the range of 0.0001 to 0.02 vol %. Diborane can also be present in a range of from 0.00002 to 0.002 vol %. The carbon- containing gas can be methane. [Figure 6]
Patent WO-2010053456-A1 (WO)
Title: Combination therapy for treatment of patients with neurological disorders and cerebral infarction
Inventor: PICARD DAVID
IPC: A61K35/646
Filed: 2009-11-10
Abstract: The present invention provides compositions and methods for treating stroke patients using traditional Chinese medicine, such as NeuroAid. The composition comprising at least one of the following Honghua, Taoren, DanGui, Deer Horn, in combination with at least one of the following: Radix Astragali root (Membranous Milkvetch root or Huang Qi), Radix et Rhizoma Salviae Miltiorrhizae root (Red Sage root or Dan Shen), Radix Paeoniae Rubra root (Red Peony root or Chi Shao), rhizome of Ligusticum Chuanxiong (Chuan Xiong), Radix et Rhizoma Notoginseng (Sanqi) Cortex moutan (Peony or Mudanpi), Wood of Odoriferous Rosewood (Jiang Xiang), dried body of Scorpion (Quan Xie), Radix Polygalae root (Yuan Zhi), Grassleaf sweetflag rhizome (Shi Changpu), Leeches (Hirudo or Shuizhi), Ground Beetle (or Tu Bie Chong), Natural or Artificial Cow-bezoar (calculus Bovis artifactus or Rengong Niuhuang), Gambirplant stem With hooks (Ramulus uncariae cum uncis or Gou Teng) and a Western medicament used for the treatment of stroke patients.
Patent SG-187268-A1 (SG)
Title: Portable access device
Inventor: HELMARS OZOLINS
IPC: H04L9/10
Filed: 2004-02-13
Abstract: PORTABLE ACCESS DEVICEPortable devices, methods, and systems for controlling access to computers and othersecure systems such as systems protecting secure premises, by processing datasupplied by the individual seeking access to the system and data supplied by thesystem to which the prospective user seeks access, to determine whether access bythe individual is to be authorized or enabled. In one embodiment the inventionprovides a device (100) for providing a code that may. be used to access a system suchas a computer or security system (600). The device comprises an output device (104)and at least one processor (105). The processor processes data representing abiometric characteristic of a prospective user of the system and a signal provided bythe system, and, depending upon a result of the processing, provides to the outputdevice a code that may be used to access the system.FIG. 1
Patent SG-161292-A1 (SG)
Title: Antibody neutralizers of human granulocyte macrophage colony stimulating factor
Inventor: RAUM TOBIAS
Filed: 2006-04-18
Abstract: The present invention relates to a human monoclonal antibody or fragment thereof which specifically binds to and neutralizes primate GM-CSF. (No suitable figure)
Patent SG-172579-A1 (SG)
Title: Voltage-limiting and reverse polarity series type led device
Inventor: YANG TAI-HER
Filed: 2010-12-21
Abstract: The present invention provides LEDs and zener diodes that arehomo-polar and connected in parallel to constitute the first set of LED and zener diode and a second set of LED and zener diode; the first LED and zener diode set and the second LED and zener diode assume a reverse polarity series connection to constitute the voltage-limiting and reversepolarity series type LED device; through the selection of connecting pins, it is used on direct current power source or alternating current power source which is its characteristics. Figure 1
Patent WO-2013077805-A1 (WO)
Title: Procédé de production d'un revêtement antimicrobien
Inventor: CHIANG NGAI MING SAMUEL
IPC: C09D7/61
Filed: 2011-11-21
Abstract: Cette invention concerne un procédé de production d'un revêtement antimicrobien ayant des propriétés de désinfection de l'air, d'auto-nettoyage et de résistance à la chaleur, le procédé comprenant les étapes de stabilisation d'un agent antimicrobien à base de silane dans l'eau à l'aide d'un agent de mouillage, d'un tensioactif et d'un polyol pour former une solution sol-gel, d'ajout d'un catalyseur photochimique ayant une taille de particules inférieure à 20 nm à la solution sol-gel, puis d'ajout d'au moins un additif de type oxyde métallique à la solution sol-gel. Le revêtement antimicrobien selon l'invention peut être appliqué à un système de conduits d'air conditionné (HVAC) ou à l'habitacle d'automobiles ou sur des surfaces de type bois et textile.
Patent SG-184581-A1 (SG)
Title: Construction structure of wall surface
Inventor: HIROSHI ITO
Filed: 2011-03-07
Abstract: CONSTRUCTION STRUCTURE OF WALL SURFACE Abstract Provided is a construction structure of wall surface having no sealing material and in which a joining portion between building boards is inconspicuous.A construction structure of wall surface includes: a hat joiner; and a building board. The hat joiner has a fixing plate portion and a design portion, and the building board has a design portion extending linearly on a surface. A joint at which the design portion of the hat joiner constitutes a design surface, and a design pattern at which the design portion of the building board constitutes a design surface, are formed in a same direction, by arranging the building board in plurality to left and right, or above and below, of the design portion of the hat joiner. A width of the joint at the design portion of the hat joiner is the same as a width of each of the design portions on the surface of each of the building boards. Alternatively, a color of the design portion of the hat joiner is the same as a color of each of the design portions of each of the building boards.Figure 1
Patent SG-170778-A1 (SG)
Title: Antitumoral compounds
Inventor: VICENTE ALBERTO RODRIGUEZ
Filed: 2008-12-19
Abstract: A compound of general formula (I), wherein, R11, R12, R13, R14, R15, W, Y, R1, R2, R3, R4, R5, and R6 take various meanings for use in the treatment of cancer.
Patent SG-171757-A1 (SG)
Title: Cartridge, a pharmaceutical dispenser containing said cartridge and applications of said cartridge and said pharmaceutical dispenser
Inventor: LEIFELD SABINE
Filed: 2009-11-14
Abstract: BHC093111AW0- FC TextCartridge, a medicament dispenser containing the cartridge, and uses of the cartridge and of the medicament dispenserAbstract:For safe storage and simple and safe administration of tablets T by a user, a cartridge 900 is provided that can be inserted into a medicament dispenser 1 for solid medicament portions T and that is designed with a reservoir for receiving the medicament portions T, and a medicament dispenser 1 containing this cartridge 900 is also provided. According to the invention, the cartridge 900 comprises a transport safety mechanism for preventing movement of the medicament portions T during storage and transport of the cartridge 900. This transport safety mechanism is in particular a tolerance compensation plug 970 that sits with a frictional fit in the reservoir and that is movable In the axial direction. The cartridge 900 also contains a tablet rider 960 which is movable in the axial direction in the reservoir end which engages through at least one axial slit in the cartridge 900 and with which a force acting in the axial direction is transferred to the medicament portions (T) in the cartridge, thus serving to hold down a column-shaped arrangement of medicament portions (T).(Fig. 4)
Patent SG-172287-A1 (SG)
Title: Sprinkler with an integrated valve, and fire-extinguishing system using same
Inventor: LEE SANG-SUN
Filed: 2009-12-24
Abstract: ]The present invention relates to a sprinkler with an integrated valve, and to a fire-extinguishing system using same. Conventional sprinklers are too sensitive to theoutbreak of a fire, and operate even if no fire has broken out, which would lead to a large amount of damage. For this reason, conventional sprinklers are often prevented from being operated in advance. In addition, sprinklers do not operate even upon the outbreak of a fire when the sensitivities thereof are lowered, rendering the sprinklers useless. The present invention aims to solve the abovementioned problems, and is configured such that a managerin a building checks whether or not a fire has broken out and if so sends an extinguishing signal, and wherein in the event a sensor for operating a sprinkler senses the outbreak of a fire, only the relevant sprinkler operates by means of a valve mounted thereon, thereby operating sprinklers only when a fire has actually broken out, and enabling a central control office, a fire station, or the like to verify the outbreak of a fire in each household at all times. Furtherthe present invention can be applied to public transportation facilities such that water-spraying is carried out after an engine room or a control board in charge of the safety of the passenger cars and outside of the latter verifies the outbreak of a fire, thus still taking advantage of a high-sensitivity of sensor. As the present invention sprinklers water only in the event of an actual fire outbreak, erroneous operation can be prevented, and water can be sprinkled only inthe required area, thereby extinguishing the fire in the early state of a fire outbreak.
Patent SG-173393-A1 (SG)
Title: Microencapsulation of biocides and antifouling agents
Inventor: HART RONALD LEE
Filed: 2005-09-14
Abstract: The present invention relates to microencapsulated compositions of isothiazolone derivatives and other water insoluble biocides or antifouling agents. In particular, the present invention relates to microencapsulated 4,5 dichloro 2 n-octyl- 3(2H)-isothiazolone(DCOIT), useful in marine antifouling coatings and paints.
Patent SG-174793-A1 (SG)
Title: Barrier
Inventor: MAWBY DANIEL
Filed: 2007-09-12
Abstract: BARRIERAbstract:A barrier fence (218) for horse racing courses and the like having a rail assembly (219), uprights (220) and ground anchors (201) for the uprights lower ends. Fence (218) can resilient deflect under side loads applied to the rail assembly, but in the event of an excessive value of such load, or of an impact load applied directly to an upright, that upright can break away from its ground anchor at its lower end. Multiple breakaway mechanisms can be provided. Upper ends of the uprights are secured to the rail assembly and in the event of an upright breaking away at its lower end it can rotate about a horizontal axis.(Figure 29)
Patent SG-181258-A1 (SG)
Title: Emergency disconnect sequence timer display and method
Inventor: EBENEZER JOSEPH PREM
Filed: 2011-11-21
Abstract: A rig control interface, system, and method. The rig control interface includes an emergency disconnect sequence button configured to initiate an emergency disconnect sequence signal to be sent to multiplex pods resulting in an emergency disconnect sequence including a plurality of functions being performed by devices in one or both of a lower marine riser package and a blowout preventer stack; and an emergency disconnect sequence timer display triggered by initiation of the emergency disconnect sequence signal, the emergency disconnect sequence timer display configured to indicate one or both of time elapsed after initiation of the emergency disconnect sequence signal and a status of the plurality of functions being performed by the devices in the one or both of the lower marine riser package and the blowout preventer stack.Figure 5A
Patent SG-177182-A1 (SG)
Title: 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands
Inventor: ALLGEIER HANS
IPC: C07D263/32
Filed: 2006-04-10
Abstract: The present invention relates to 1H-Quinazoline-2,4-diones of formula (I)   
wherein R 1  and R 2  are as defined in the specification, their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them. Further, intermediates for the manufacture of compounds of formula (I) are and combinations comprising compounds of formula (I) are disclosed.
Patent SG-177302-A1 (SG)
Title: Methods and products for treatment of diseases
Inventor: BAR-OR DAVID
Filed: 2010-06-22
Abstract: The invention provides a method of treating a disease or condition mediated by vascular hyperpermeability in an animal. The method comprises administering an amount of a danazol compound effective to inhibit vascular hyperpermeability and an amount of a second drug effective to treat the disease or condition. The invention further provides a method of inhibiting vascular hyperpermeability when it is a side effect caused by administration of a drug to, or another treatment of, an animal. The method comprises administration of an amount of a danazol compound effective to inhibit the vascular hyperpermeability. The invention also provides a method of modulating the cytoskeleton of endothelial cells in an animal comprising administering an amount of a danazol compound and an amount of a second drug effective to modulate the cytoskeleton. The present invention also relates to pharmaceutical compositions and kits comprising a danazol compound and a second drug.
Patent WO-2013074043-A1 (WO)
Title: Criblage in vivo pour des antagonistes de la voie hedgehog (hh)
Inventor: INGHAM PHILIP WILLIAM
IPC: C12Q1/68
Filed: 2012-11-19
Abstract: L'invention concerne un poisson de la famille des  Cyprinidae  comprenant un gène Kif7 inhibé et dans lequel le poisson est homozygote pour le gène Kif7 inhibé.
Patent SG-195394-A1 (SG)
Title: Compositions and methods for metabolic selection of transfected cells
Inventor: LUIS BRANCO
Filed: 2006-05-18
Abstract: The present invention relates to novel selection marker vectors, and methods for using these vectors to generate stable gene expression systems in eukaryotic cells. More specifically, the present invention provides compositions and methods utilizing any enzyme useful in the eukaryotic sterol/cholesterol biosynthetic pathway, such as a 3- ketosteroid reductase, as a metabolic selection marker to select transfected cells. In one embodiment, the method comprises transfecting cells that are auxotrophic for cholesterol with a vector encoding 3- ketosteroid reductase and at least one heterologous protein, and selecting cells that have the ability to survive in medium lacking cholesterol and/or producing the heterologous protein in these cells in chemically defined and/or serum-free media.Figure 2
Patent SG-184915-A1 (SG)
Title: Oligomerization catalyst system and process for oligomerizing olefins
Inventor: SYDORA ORSON L
Filed: 2011-04-21
Abstract: Among other things, this disclosure provides an olefin oligomerization system and process, the system comprising: a) a transition metal compound; b) a pyrrole compound having a hydrogen atom on at the 5- position or the 2- and 5- position of a pyrrole compound and having a bulky substituent located on each carbon atom adjacent to the carbon atom bearing a hydrogen atom at the 5- position or the 2- and 5- position of a pyrrole compound. These catalyst system have significantly improved productivities, selectivities to 1-hexene, and provides higher purity 1-hexene within the C6 fraction than catalyst systems using 2,4-dimethyl pyrrole.
Patent SG-186356-A1 (SG)
Title: Novel antibody for the diagnosis and/or prognosis of cancer
Inventor: JOUHANNEAUD ALEXANDRA
Filed: 2011-06-29
Abstract: The present invention relates to the field of prognosis and/or diagnosis of a proliferative disease in a patient. More particularly, the invention relates to novel antibodies capable of binding specifically to the human cMet receptor, as well as the amino acid and nucleic acid sequences coding for these antibodies. The invention likewise comprises the use of said antibodies, and corresponding process, for detecting and diagnosing pathological hyperproliferative oncogenic disorders associated with expression of cMet. In certain embodiments, the disorders are oncogenic disorders associated with increased expression of cMet polypeptide relative to normal or any other pathology connected with the over expression of c Met. The invention finally comprises products and/or compositions or kits comprising at least such antibodies for the prognosis or diagnostic of certain cancers.
Patent SG-189822-A1 (SG)
Title: Driving assistance service providing device, processing device, and control method
Inventor: HATTORI YURIKO
Filed: 2011-11-16
Abstract: DRIVING ASSISTANCE SERVICE PROVIDING DEVICE, PROCESSING DEVICE, AND CONTROL METHODA processing device includes: an external-device-function-identification-unitidentifies a function of each external device; a data-type-identification-unit identifies a type of data received from an external device via an interface (150, 160, 170, or 180); a providing-service-selection-unit selects one service to be provided from among various services registered in advance as services for assisting with driving of a vehicle based onthe type of data identified by the data-type-identification-unit; a function-corresponding data-generation-unit generates an output data for an external device functioning as an output device among functions of external devices identified by the external-device function-identification-unit by executing processing corresponding to the service selected by the providing-service-selection-unit using the data of the external device; and afunction-corresponding-data-output-unit outputs the data generated by the-function corresponding-data-generation-unit to the external device functioning as the output device.Figure 1
Patent SG-187770-A1 (SG)
Title: A liposomal formulation for ocular drug delivery
Inventor: VENKATRAMAN SUBRAMANIAN
Filed: 2011-08-12
Abstract: The present invention is directed to a liposomal formulation for ocular drug delivery comprising (i) liposomes comprising at least one lipid bilayer, and (ii) a prostaglandin drug and/or a prostaglandin derivative associated in the liposomes, wherein the liposomes have a mean diameter of less than 2 μπι. The present invention is also directed to a pharmaceutical comprising the liposomal formulation and a method of producing the liposomal formulation for ocular drug delivery. Additionally, the present invention is directed to a method of treating or preventing an ocular disease, comprising administering the liposomal formulation or the pharmaceutical composition to a subject in need thereof.
Patent SG-188204-A1 (SG)
Title: Improved anti-serum albumin binding variants
Inventor: DE ANGELIS ELENA
Filed: 2011-08-12
Abstract: The invention relates to improved variants of the anti-serum albumin immunoglobulin single variable domain DOM7h-14-10, as well as ligands and drug conjugates comprising such variants, compositions, nucleic acids, vectors and hosts.
Patent SG-192107-A1 (SG)
Title: Gel-encapsulated microcolony screening
Inventor: AGRESTI JEREMY
Filed: 2012-01-27
Abstract: Provided herein are methods and compositions useful for detecting the production of industrially useful compounds (e.g., isoprenoids, polyketides, and fatty acids) in a cell, for example, a microbial cell genetically modified to produce one or more such compounds. In some embodiments, the methods comprise encapsulating the cell in a hydrogel particle, and detecting the compound within the hydrogel particle.
Patent WO-2018106187-A1 (WO)
Title: Système et procédé de réduction de la fraude dans l'assurance du commerce et le financement
Inventor: LEDESMA MAUREEN NOVA CHUA
IPC: G06Q40/08
Filed: 2017-12-06
Abstract: L'invention concerne un système et un procédé destinés à mettre en place l'assurance du commerce et la finance. Le système comporte une commande centrale disposée en communication avec une ou plusieurs bases de données pour obtenir électroniquement des informations à partir des bases de données, les informations comprenant une facture, et un pivot à chaînes de blocs relié opérationnellement à la commande centrale pour faire circuler les informations de la commande centrale à une ou plusieurs plates-formes. Le pivot à chaînes de blocs, au niveau duquel des connaissements sont également codés et validés, est capable de générer une sortie de réponse de hachage d'après une demande provenant de la ou des plates-formes, et si la facture satisfait au moins un critère prédéterminé, la commande centrale fournit la facture à un assureur pour l'assurance et à un prêteur pour financer la facture.
Patent WO-2021021019-A1 (WO)
Inventor: QUEK SEOW HENG SAMUEL
IPC: B65H75/42
Filed: 2020-07-24
Abstract: The present invention discloses a weather protection device for a light transport vehicle comprising a tubular housing adapted for mounting to a front portion of the light transport vehicle, the tubular housing including a slot extending longitudinally along the tubular housing, a front cover located within the tubular housing and configured to extend from the slot, a main bar assembly including a first side connected to an end of the front cover and a second side housing a rear cover retractable from the main bar assembly and adapted for mounting to a rear portion of the light transport vehicle.